Bishop M J, Huang T, Cheney F W
Am Rev Respir Dis. 1985 Mar;131(3):421-5. doi: 10.1164/arrd.1985.131.3.421.
Diffuse pulmonary injury is accompanied by reduction of blood flow to injured areas because of local pulmonary vasoconstriction, vascular thrombosis, and vascular obliteration. To assess whether reduced pulmonary arterial blood flow might produce relative ischemia in injured areas and consequent potentiation of the injury, we studied the effects of vasodilator treatment in a dog model of diffuse alveolar damage. Twenty-five awake dogs with arterial and pulmonary arterial catheters in place were given 0.08 ml/kg oleic acid, a dose that produces a diffuse lung injury that largely resolves over a 1-wk period. Ten of the animals were treated with minoxidil, a potent vasodilator and inhibitor of hypoxic pulmonary vasoconstriction. Observations were made for a total of 96 h. At 24 h, treated animals had lower pulmonary vascular resistance (207 +/- 85 versus 348 +/- 136 dyne X s X cm-5, p less than 0.01) but higher venous admixture (30 +/- 10% versus 18 +/- 12%, p less than 0.05) and thermodilution-measured lung water (17 +/- 8 ml/kg versus 9 +/- 2 ml/kg, p less than 0.05). However, by 96 h, there were no differences between the 2 groups in any measured parameters of hemodynamic status, gas exchange, or histologic examination. We conclude that pulmonary vasodilation increased blood flow to injured areas but did not affect eventual resolution of the injury.
弥漫性肺损伤伴有局部肺血管收缩、血管血栓形成和血管闭塞,导致损伤区域血流减少。为了评估肺动脉血流减少是否会在损伤区域产生相对缺血并进而加重损伤,我们在弥漫性肺泡损伤的犬模型中研究了血管扩张剂治疗的效果。对25只清醒的、已植入动脉和肺动脉导管的犬给予0.08 ml/kg油酸,该剂量可导致弥漫性肺损伤,且大部分损伤在1周内消退。其中10只动物用米诺地尔治疗,米诺地尔是一种强效血管扩张剂和低氧性肺血管收缩抑制剂。总共观察96小时。在24小时时,治疗组动物的肺血管阻力较低(分别为207±85与348±136达因·秒·厘米⁻⁵,p<0.01),但静脉混合血较高(分别为30±10%与18±12%,p<0.05),且热稀释法测得的肺水含量较高(分别为17±8 ml/kg与9±2 ml/kg,p<0.05)。然而,到96小时时,两组在血流动力学状态、气体交换或组织学检查的任何测量参数上均无差异。我们得出结论,肺血管扩张增加了损伤区域的血流,但并未影响损伤的最终恢复。